

Redefining Neuroimaging for Faster Decisions
ZRO Imaging (ZRO) makes imaging a strategic advantage, not a bottleneck. Our team includes recognized scientific leaders with hands-on experience in PET and MRI for neurodegenerative diseases, bringing focus, precision, and accountability to every project.
We make imaging a strategic advantage, not a bottleneck. Our team includes recognized scientific leaders with hands-on experience in PET and MRI for neurodegenerative diseases, bringing focus, precision, and accountability to every project.
We work closely with biopharma, diagnostics, and research consortia developing new therapies and biomarkers for neurodegenerative disease.
We don’t just support clinical programs; we move them forward. ZRO stands for more than our name: zero delays, zero unnecessary complexity, and a future with zero neurodegenerative disease.

We help sponsors collect, validate, and interpret imaging data with precision — cutting complexity, minimizing risk, and keeping studies moving.
From first scan to final readout, our focus is simple: make imaging faster, clearer, and built for confident decisions.
01
Every strong dataset starts with a precise plan.
ZRO designs PET and MRI protocols that connect scientific precision with operational simplicity.
Standardized methods across sites cut variability and eliminate the downstream delays that slow most trials.
02
Every successful study depends on control and consistency.
ZRO qualifies imaging sites, trains teams on study-specific procedures, and stays closely involved from first scan to final upload.
Real-time QC and direct communication keep data aligned and issues resolved before they affect timelines.
03
Once images are acquired, precision handling begins.
All PET and MRI data are stored and processed within validated systems with full traceability.
Each scan undergoes visual QC for quality and protocol compliance, with central reads and quantitative analysis performed when part of the study scope
04
New PET tracers and exploratory biomarkers demand flexibility.
We design and execute imaging for early-phase and translational programs, integrating PET, MRI, and fluid biomarkers to evaluate tracer behavior, disease mechanisms, and therapeutic effects.
Our scientific guidance and rigorous QC ensure that innovation moves forward without compromising data quality or reliability.

Most imaging CROs focus on execution. ZRO goes further, shaping the imaging strategy, staying close to every detail, and delivering data that meet the highest scientific and operational standards.
Our strength lies in combining scientific depth with operational speed. We anticipate challenges, act quickly, and keep trials moving—so imaging becomes a source of clarity, not unnecessary complexity.
That’s The ZRO Way: expert-led execution, no layers, no friction, and a high-ownership culture that drives projects forward without delay.
Our decentralized model empowers teams to act quickly and decisively. Precision and speed come together naturally in how we work.